Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Tarsons Products's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,185.82 | 1,080.04 | 972.18 |
| Other Liabilities Total | 60.1 | 52.39 | 25.19 |
| Long Term Debt | 209.53 | 204.87 | 102.01 |
| Common Stock Total | 10.64 | 10.64 | 10.64 |
| Other Equity Total | 624.05 | -0.61 | 1.05 |
| Other Current Assets Total | 23.16 | Not available | Not available |
| Total Assets | 1,185.82 | 1,080.04 | 972.18 |
| Current Portof LT Debt/Capital Leases | 176.95 | 57.67 | 55.08 |
| Cash | 25.26 | 25.13 | 17.11 |
| Total Equity | 634.69 | 630.21 | 612.86 |
| Long Term Investments | 9.59 | 0.83 | 0.07 |
| Total Common Shares Outstanding | 5.32 | 5.32 | 5.32 |
| Tangible Book Valueper Share Common Eq | 108.06 | 106.37 | 102.19 |
| Goodwill Net | 32.53 | 32.53 | 32.53 |
| Total Liabilities | 551.13 | 449.83 | 359.32 |
| Total Debt | 392.96 | 339.17 | 269.02 |
| Short Term Investments | 0.15 | 0.63 | 5.53 |
| Cashand Short Term Investments | 25.41 | 25.76 | 22.64 |
| Total Receivables Net | 87.41 | 81.97 | 78.5 |
| Deferred Income Tax | 10.84 | 9.39 | 9.22 |
| Property/Plant/Equipment Total-Net | 831.53 | 704.66 | 533.69 |
| Total Current Liabilities | 264.19 | 175.73 | 213.16 |
| Total Inventory | 129.78 | 133.56 | 133.2 |
| Accounts Payable | 20.31 | 15.71 | 14.64 |
| Other Currentliabilities Total | 66.93 | 33.17 | 41.25 |
| Total Long Term Debt | 216.01 | 212.31 | 111.76 |
| Intangibles Net | 27.19 | 31.74 | 36.6 |
| Other Long Term Assets Total | 16.13 | 3.69 | 4.65 |
| Note Receivable-Long Term | 3.1 | 64.01 | 129.37 |
| Total Current Assets | 265.75 | 242.58 | 235.28 |
| Capital Lease Obligations | 6.48 | 7.45 | 9.75 |
| Accumulated Depreciation Total | Not available | -187.36 | -130.2 |
| Prepaid Expenses | Not available | 1.29 | 0.93 |
| Additional Paid-In Capital | Not available | 145.91 | 145.91 |
| Retained Earnings(Accumulated Deficit) | Not available | 474.27 | 455.26 |
| Property/Plant/Equipment Total-Gross | Not available | 659.17 | 396.86 |
| Notes Payable/Short Term Debt | Not available | 69.18 | 102.18 |
| Accounts Receivable-Trade Net | Not available | 79.55 | 77.82 |
| Cash Equivalents | Not available | Not available | 0 |
Debt 5Yr CAGR %71.61
Operating Margin 12m4.8
Operating Margin 5y Avg21.23
Net Profit Margin 12m3.39
Net Profit Margin 5y15.81
Dividend Yield %0
Price to Sale Ratio3.92
Overall RiskHigh risk
Board Risk55.84
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Shivalik Bimetal Controls | INR 741.4 | 4,286.46 | 43.99 | — |
| Rishabh Instruments | INR 644.75 | 2,476.01 | 31.06 | — |
| Rolcon Engineering Company | INR 540.75 | 38.98 | 12.5 | — |
| EPIC Energy | INR 35.1 | 25.31 | 36.54 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Tarsons Products Limited is an India-based labware company. The Company is engaged in designing, development, manufacturing and marketing of consumables, reusables and others including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies contract research organizations (CROs), diagnostic companies and hospitals. The Company is also engaged in the manufacturing of range a of labware products which helps scientific discovery and improve healthcare. The Company has developed a diverse range of labware products under the categories: consumables, reusables and others. The Company's consumables products include pipette tips, centrifuge ware, petri dishes, cryo ware and storage vials. Its reusable products include bottles and carboys, beakers, cylinders and racks. It also offers polymerase chain reaction (PCR) and cell culture products.
Tarsons Products has the symbol TARSONS and ISIN - INE144Z01023.
Tarsons Products is currently trading at INR 305.50.
Tarsons Products has a year high of INR 375.00 and a year low of INR 164.45.
Tarsons Products has a market capitalization of INR 1,655.80 crore.
Tarsons Products has a P/E ratio of 61.65.
Tarsons Products has a dividend yield of 0.00%.
Tarsons Products has revenue of INR 422.51 crore, net income of INR 14.32 crore, and EPS of INR 2.84.
Tarsons Products has a book value of INR 108.06.
Tarsons Products has a debt-to-equity ratio of NA.
Tarsons Products has a price-to-book ratio of 2.83 and a price-to-sales ratio of 3.92.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.